|Articles|July 15, 2002
Blue-light damage is well-established risk in pseudophakia
Like most ophthalmologists, I knew little about the significant body of work in the peer-review literature documenting the harmful effects of visible blue-wavelength light on the retina. Because an effective solution to the problem seems to be on the way, the time has come for us to begin to recognize the implications of blue-light exposure in pseudophakic patients.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement